Spero Therapeutics, Inc.
SPRONasdaqCIK 1701108HealthcareFiscal year ends Dec 31
Reports and events: 174 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0108:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-267758 |
| 2023-10-1616:01 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-256865 |
| 2023-10-1008:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-253136 |
| 2023-09-0116:08 ET | DEF 14A | Proxy statementPeriod 2023-10-05 | 0001193125-23-227642 |
| 2023-08-1016:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-209064 |
| 2023-08-1016:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041314 |
| 2023-07-3108:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-198589 |
| 2023-06-1408:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-166543 |
| 2023-05-1116:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-142023 |
| 2023-05-1116:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021187 |
| 2023-03-3016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-085566 |
| 2023-03-3016:02 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-010921 |
| 2023-02-0116:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-021612 |
| 2023-01-0908:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-004190 |
| 2022-11-1416:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-284579 |
| 2022-11-1416:04 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024971 |
| 2022-11-0808:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-279724 |
| 2022-09-2208:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-248772 |
| 2022-09-1917:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-247168 |
| 2022-09-0608:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-238439 |
| 2022-08-1016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-217351 |
| 2022-08-1016:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016443 |
| 2022-08-0516:06 ET | DEF 14A | Proxy statementPeriod 2022-09-15 | 0001193125-22-213583 |
| 2022-07-0116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-187190 |
| 2022-06-2716:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-182828 |
| 2022-06-0716:01 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-169252 |
| 2022-05-1616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-151708 |
| 2022-05-1616:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-010064 |
| 2022-05-0307:15 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-137586 |
| 2022-04-0717:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-097712 |
| 2022-03-3116:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-091793 |
| 2022-03-3116:02 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-005194 |
| 2022-02-1608:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-044007 |
| 2022-01-2508:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-016568 |
| 2022-01-1908:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-011967 |
| 2022-01-0408:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-001112 |
| 2021-11-1016:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-326025 |
| 2021-11-1016:02 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004064 |
| 2021-10-2808:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-310428 |
| 2021-10-1208:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-296407 |
| 2021-09-3008:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-21-287391 |
| 2021-08-3016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-260572 |
| 2021-08-1816:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-250505 |
| 2021-08-0516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-237754 |
| 2021-08-0516:02 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-000924 |
| 2021-07-0612:39 ET | DEF 14A | Proxy statementPeriod 2021-08-17 | 0001193125-21-208448 |
| 2021-07-0119:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-21-205054 |
| 2021-05-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-153274 |
| 2021-05-0616:02 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-024932 |
| 2021-03-2316:02 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001193125-21-091148 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.